• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ideaya Biosciences Inc (NQ: IDYA )

    29.58 +0.33 (+1.13%)
    Streaming Delayed Price Updated: 1:37 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 314,465
    Open 29.39
    Bid (Size) 29.57 (2)
    Ask (Size) 29.64 (2)
    Prev. Close 29.25
    Today's Range 29.05 - 29.79
    52wk Range 23.41 - 47.73
    Shares Outstanding 48,390,394
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
    IDEAYA Biosciences released interim Phase 2 data that shows promising tumor shrinkage and eye preservation rates. 
    Via Benzinga
    Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga

    Performance

    YTD
    -16.01%
    -16.01%
    1 Month
    -22.38%
    -22.38%
    3 Month
    -13.66%
    -13.66%
    6 Month
    -28.55%
    -28.55%
    1 Year
    +16.09%
    +16.09%

    More News

    Read More
    IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024
    Via InvestorPlace
    Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
    Via Talk Markets
    MarketBeat Week in Review – 7/15 - 7/19
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    Unveiling 5 Analyst Insights On IDEAYA Biosciences
    Via Benzinga
    Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
    Via Benzinga
    The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
    Via Benzinga
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    Via MarketBeat
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Recap: IDEAYA Biosciences Q4 Earnings
    Via Benzinga
    The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
    Via Benzinga
    Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
    Via Benzinga
    Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24
    Via Investor Brand Network
    IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19
    Via Investor Brand Network
    Why Ideaya Biosciences Just Made Its Most Bullish Move Since March
    Via Investor's Business Daily
    Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024
    Via InvestorPlace
    Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
    Via Benzinga
    Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine
    Via Talk Markets
    Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
    Via Benzinga
    8 Analysts Have This to Say About IDEAYA Biosciences
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.